Grey Street Capital’s Organon & Co OGN Stock Holding History

Grey Street Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-61,456	Closed	-$434	–	141
2023 Q3	$434	Buy	+61,456	New	+$1.28M	﹤0.01%	129

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Grey Street Capital's OGN Position: Q4 2023 in Review

Grey Street Capital sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 61,456 shares — an estimated $434 sold.

Grey Street Capital first reported a position in OGN in Q3 2023 and held it in 1 quarter. The position peaked at $434 in Q3 2023. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

Grey Street Capital reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
Grey Street Capital sold 61,456 Organon & Co shares in Q4 2023, an estimated $434.
Grey Street Capital first reported a position in Organon & Co in Q3 2023 and held it in 1 quarter.
Grey Street Capital's Organon & Co position peaked at $434 in Q3 2023.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Grey Street Capital's 13F filing for Q4 2023, filed 11 Jan 2024.